[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Fortress Biotech Inc (FBIO)

Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 97,332
  • Shares Outstanding, K 33,219
  • Annual Sales, $ 63,260 K
  • Annual Income, $ 6,820 K
  • EBIT $ -51 M
  • EBITDA $ -43 M
  • 60-Month Beta 1.21
  • Price/Sales 1.56
  • Price/Cash Flow N/A
  • Price/Book 0.49

Options Overview Details

View History
  • Implied Volatility 148.24% (+35.00%)
  • Historical Volatility 78.20%
  • IV Percentile 46%
  • IV Rank 10.83%
  • IV High 1,000.47% on 11/10/25
  • IV Low 44.74% on 05/19/26
  • Expected Move (DTE 5) 0.02 (0.58%)
  • Put/Call Vol Ratio 2.30
  • Today's Volume 99
  • Volume Avg (30-Day) 149
  • Put/Call OI Ratio 0.71
  • Today's Open Interest 9,277
  • Open Int (30-Day) 8,683
  • Expected Range 2.91 to 2.95

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $0.11
  • Growth Rate Est. (year over year) +908,081.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.57 +14.01%
on 08/12/26
3.84 -23.70%
on 07/15/26
-0.80 (-21.45%)
since 07/14/26
3-Month
2.27 +29.36%
on 05/15/26
3.84 -23.70%
on 07/15/26
+0.63 (+27.39%)
since 05/14/26
52-Week
1.97 +48.73%
on 08/15/25
4.53 -35.32%
on 01/09/26
+0.97 (+49.49%)
since 08/14/25

Most Recent Stories

More News
Fortress Biotech: Q2 Earnings Snapshot

Fortress Biotech: Q2 Earnings Snapshot

FBIO : 2.93 (-1.68%)
Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

Total net revenue increased 14% to $18.7 million for second quarter of 2026 compared to second quarter of 2025 Partnered programs continue to advance with Crystalys Therapeutics announcing its $130...

FBIO : 2.93 (-1.68%)
FBIOP : 18.66 (-2.38%)
Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

Total revenues were $18.5 million for the second quarter of 2026, reflecting 23% growth from the prior-year quarter  Emrosi ® revenues were $8.1 million for the second quarter of 2026 ...

FBIO : 2.93 (-1.68%)
DERM : 6.72 (+1.05%)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duties by Certain Officers and Directors of Fortress Biotech, Inc. (NASDAQ: FBIO)

NEW YORK , Aug. 7, 2026 /PRNewswire/ -- Levi & Korsinsky announces that it has commenced an investigation of Fortress Biotech, Inc. (NASDAQ: FBIO) concerning possible breaches of fiduciary duties....

FBIO : 2.93 (-1.68%)
Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026

SCOTTSDALE, Ariz., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or the “Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company primarily focused...

FBIO : 2.93 (-1.68%)
DERM : 6.72 (+1.05%)
Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing

MIAMI, July 27, 2026 (GLOBE NEWSWIRE) -- Urica Therapeutics, Inc. (“Urica” or the “Company”), a Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”) subsidiary, today announced that Crystalys...

FBIO : 2.93 (-1.68%)
FBIOP : 18.66 (-2.38%)
Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference

SCOTTSDALE, Ariz., May 19, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical,” “the Company,” “we” or “our”), a commercial-stage pharmaceutical company...

FBIO : 2.93 (-1.68%)
DERM : 6.72 (+1.05%)
Fortress Biotech to Participate in A.G.P.’s Annual Virtual Healthcare Conference

MIAMI, May 18, 2026 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term...

FBIO : 2.93 (-1.68%)
FBIOP : 18.66 (-2.38%)
Fortress Biotech: Q1 Earnings Snapshot

Fortress Biotech: Q1 Earnings Snapshot

FBIO : 2.93 (-1.68%)
Fortress Biotech Reports First Quarter 2026 Financial Results and Recent Corporate Highlights

ZYCUBO ® approved by FDA to treat Menkes disease in the United States; Fortress subsidiary Cyprium Therapeutics closed the sale of its Rare Pediatric Disease Priority Review Voucher (PRV) for $205 million...

FBIO : 2.93 (-1.68%)
FBIOP : 18.66 (-2.38%)

Business Summary

Fortress Biotech, Inc. is a biopharmaceutical company. The company is engaged in acquiring, developing and commercializing novel pharmaceutical and biotechnology products. Fortress Biotech, Inc., formerly known as Coronado Biosciences, Inc., is based in NEW YORK, United States.

See More

Key Turning Points

3rd Resistance Point 3.37
2nd Resistance Point 3.20
1st Resistance Point 3.06
Last Price 2.93
1st Support Level 2.75
2nd Support Level 2.58
3rd Support Level 2.44

See More

52-Week High 4.53
Fibonacci 61.8% 3.55
Fibonacci 50% 3.25
Fibonacci 38.2% 2.95
Last Price 2.93
52-Week Low 1.97

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.